China Animal Husbandry Ind. operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Animal Husbandry Ind. with three other
companies in this sector in China:
Tonghua Dongbao Medicines Company Limited
sales of 2.54 billion Chinese Renmimbi [US$371.17 million]
of which 89%
China Biologic Products Holdings Inc
(2.49 billion Chinese Renmimbi [US$364.34 million]
of which 100%
was Human Blood Product), and
Yifan Pharmaceutical Co Ltd
(4.37 billion Chinese Renmimbi [US$638.72 million]
of which 50%
was Health Products - Medicine).
During the year ended December of 2017, sales at
China Animal Husbandry Ind. were 4.07 billion Chinese Renmimbi (US$594.38 million).
increase of 2.4%
versus 2016, when the company's sales were 3.97 billion Chinese Renmimbi.
Despite this increase, sales are still
below the level achieved in 2015, when China Animal Husbandry Ind.
reported sales of 4.23 billion Chinese Renmimbi.
Sales of Animal Disease Treatment saw an increase
that was more than double the company's growth rate: sales were up
13.8% in 2017, from
743.77 million Chinese Renmimbi to 846.37 million Chinese Renmimbi.
China Animal Husbandry Ind. also saw significant increases in sales in
Animal Feedstuff (up 6.7% to 2.03 billion Chinese Renmimbi)
Not all segments of China Animal Husbandry Ind. experienced an increase in sales in 2017:
sales of Other fell 14.6% to 21.67 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).
China Animal Husbandry Ind. also experienced decreases in sales in
Animal Disease and Epidemic Prevention (down 10.0% to 1.17 billion Chinese Renmimbi)